Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014)

Vertex Pharmaceuticals (VRTX) posted quarterly Current Taxes of $14.2 million for Q4 2014, up 1886.85% quarter-over-quarter from $715000.0 in Q4 2012.

Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014) Analysis & Trends

Vertex Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $14.2 million for Q4 2014.

  • In Q4 2014, Current Taxes changed N/A year-over-year to $14.2 million; the TTM figure through Dec 2014 stood at $14.2 million (changed N/A YoY), while the FY2014 annual figure was $14.2 million, changed N/A from the prior year.
  • Current Taxes for Q4 2014 stood at $14.2 million, up from $715000.0 in the prior quarter.
  • The five-year high for Current Taxes was $14.2 million in Q4 2014, with the low at $201000.0 in Q1 2012.
  • The 3-year median for Current Taxes is $3.9 million (2012), against an average of $5.9 million.
  • Peak annual rise in Current Taxes reached 60.32% in 2012, while the deepest fall reached 94.08% in 2012.
  • Vertex Pharmaceuticals' Current Taxes stood at $12.1 million in 2011, then tumbled by 94.08% to $715000.0 in 2012, then soared by 1886.85% to $14.2 million in 2014.
  • Business Quant data shows VRTX's Current Taxes at $14.2 million in Q4 2014, $715000.0 in Q4 2012, and $3.9 million in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 49.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 76.32 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 59,089.99
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 74.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2014 14.21 Mn
Dec 31, 2012 715,000.00
Sep 30, 2012 3.87 Mn
Jun 30, 2012 201,000.00
Mar 31, 2012 201,000.00
Dec 31, 2011 12.08 Mn
Sep 30, 2011 9.76 Mn